Wire · opportunities
Bayer wins FDA nod for a new kind of blood thinner
◆ Sectors
Drug Discovery
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 10 November 2026 · Fusion42 review
Bayer received FDA approval for Sunharbo, a new type of blood thinner classified as a Factor XIa inhibitor, which represents a novel class of stroke prevention medication.
This Wire brief sits within Fusion42's coverage of Drug Discovery, and 3 sources have reported it.
◆ ◆ The Wire takeaway
You can now build on a new FDA-approved drug class that may change stroke prevention treatment standards and open up new competitive opportunities.
◆ Coverage
3 sources · 10 Nov 2026
◆ Related on Wire
◆ Topics
Drug Discoveryfda-approvalblood-thinnerstroke-preventionfactor-xia-inhibitorbayer